The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

C. Verslype; E. Van Cutsem; M. Dicato; N. Arber; J. D. Berlin; D. Cunningham; A. De Gramont; E. Diaz-Rubio; M. Ducreux; T. Gruenberger; D. Haller; K. Haustermans; P. Hoff; D. Kerr; R. Labianca; M. Moore; B. Nordlinger; A. Ohtsu; P. Rougier; W. Scheithauer; H. J. Schmoll; A. Sobrero; J. Tabernero; C. van de Velde

doi:10.1093/annonc/mdp281

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

C. Verslype, E. Van Cutsem, M. Dicato, N. Arber, J. D. Berlin, D. Cunningham, A. De Gramont, E. Diaz-Rubio, M. Ducreux, T. Gruenberger, D. Haller, K. Haustermans, P. Hoff, D. Kerr, R. Labianca, M. Moore, B. Nordlinger, A. Ohtsu, P. Rougier, W. ScheithauerH. J. Schmoll, A. Sobrero, J. Tabernero, C. van de Velde

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

101 Citations (Scopus)

Résumé

This article summarizes the expert discussion on the management of hepatocellular carcinoma (HCC), which took place during the 10th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, June 2008. A multidisciplinary approach to a patient with HCC is essential, to guarantee optimal diagnosis and staging, planning of surgical options and selection of embolisation strategies or systemic therapies. In many patients, the underlying cirrhosis represents a challenge and determines therapeutic options. There is now robust evidence in favour of systemic therapy with sorafenib in patients with advanced HCC with preserved liver function. Those involved in the care for patients with HCC should be encouraged to participate in well-designed clinical trials, to increase evidence-based knowledge and to make further progress.

langue originale	Anglais
Pages (de - à)	1-6
Nombre de pages	6
journal	Annals of Oncology
Volume	20
Numéro de publication	SUPPL.7
Les DOIs	https://doi.org/10.1093/annonc/mdp281
état	Publié - 1 janv. 2009

Accès au document

10.1093/annonc/mdp281

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Verslype, C., Van Cutsem, E., Dicato, M., Arber, N., Berlin, J. D., Cunningham, D., De Gramont, A., Diaz-Rubio, E., Ducreux, M., Gruenberger, T., Haller, D., Haustermans, K., Hoff, P., Kerr, D., Labianca, R., Moore, M., Nordlinger, B., Ohtsu, A., Rougier, P., ... van de Velde, C. (2009). The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Annals of Oncology, 20(SUPPL.7), 1-6. https://doi.org/10.1093/annonc/mdp281

@article{c3dea157569c4f5c81e0a79d54866fd5,

title = "The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008",

abstract = "This article summarizes the expert discussion on the management of hepatocellular carcinoma (HCC), which took place during the 10th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, June 2008. A multidisciplinary approach to a patient with HCC is essential, to guarantee optimal diagnosis and staging, planning of surgical options and selection of embolisation strategies or systemic therapies. In many patients, the underlying cirrhosis represents a challenge and determines therapeutic options. There is now robust evidence in favour of systemic therapy with sorafenib in patients with advanced HCC with preserved liver function. Those involved in the care for patients with HCC should be encouraged to participate in well-designed clinical trials, to increase evidence-based knowledge and to make further progress.",

keywords = "Chemoembolisation, Hepatocellular carcinoma, Liver transplantation, Sorafenib",

author = "C. Verslype and {Van Cutsem}, E. and M. Dicato and N. Arber and Berlin, {J. D.} and D. Cunningham and {De Gramont}, A. and E. Diaz-Rubio and M. Ducreux and T. Gruenberger and D. Haller and K. Haustermans and P. Hoff and D. Kerr and R. Labianca and M. Moore and B. Nordlinger and A. Ohtsu and P. Rougier and W. Scheithauer and Schmoll, {H. J.} and A. Sobrero and J. Tabernero and {van de Velde}, C.",

year = "2009",

month = jan,

day = "1",

doi = "10.1093/annonc/mdp281",

language = "English",

volume = "20",

pages = "1--6",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "SUPPL.7",

}

Verslype, C, Van Cutsem, E, Dicato, M, Arber, N, Berlin, JD, Cunningham, D, De Gramont, A, Diaz-Rubio, E, Ducreux, M, Gruenberger, T, Haller, D, Haustermans, K, Hoff, P, Kerr, D, Labianca, R, Moore, M, Nordlinger, B, Ohtsu, A, Rougier, P, Scheithauer, W, Schmoll, HJ, Sobrero, A, Tabernero, J & van de Velde, C 2009, 'The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008', Annals of Oncology, VOL. 20, Numéro SUPPL.7, p. 1-6. https://doi.org/10.1093/annonc/mdp281

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. / Verslype, C.; Van Cutsem, E.; Dicato, M. et al.
Dans: Annals of Oncology, Vol 20, Numéro SUPPL.7, 01.01.2009, p. 1-6.

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

TY - JOUR

T1 - The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

AU - Verslype, C.

AU - Van Cutsem, E.

AU - Dicato, M.

AU - Arber, N.

AU - Berlin, J. D.

AU - Cunningham, D.

AU - De Gramont, A.

AU - Diaz-Rubio, E.

AU - Ducreux, M.

AU - Gruenberger, T.

AU - Haller, D.

AU - Haustermans, K.

AU - Hoff, P.

AU - Kerr, D.

AU - Labianca, R.

AU - Moore, M.

AU - Nordlinger, B.

AU - Ohtsu, A.

AU - Rougier, P.

AU - Scheithauer, W.

AU - Schmoll, H. J.

AU - Sobrero, A.

AU - Tabernero, J.

AU - van de Velde, C.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - This article summarizes the expert discussion on the management of hepatocellular carcinoma (HCC), which took place during the 10th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, June 2008. A multidisciplinary approach to a patient with HCC is essential, to guarantee optimal diagnosis and staging, planning of surgical options and selection of embolisation strategies or systemic therapies. In many patients, the underlying cirrhosis represents a challenge and determines therapeutic options. There is now robust evidence in favour of systemic therapy with sorafenib in patients with advanced HCC with preserved liver function. Those involved in the care for patients with HCC should be encouraged to participate in well-designed clinical trials, to increase evidence-based knowledge and to make further progress.

AB - This article summarizes the expert discussion on the management of hepatocellular carcinoma (HCC), which took place during the 10th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, June 2008. A multidisciplinary approach to a patient with HCC is essential, to guarantee optimal diagnosis and staging, planning of surgical options and selection of embolisation strategies or systemic therapies. In many patients, the underlying cirrhosis represents a challenge and determines therapeutic options. There is now robust evidence in favour of systemic therapy with sorafenib in patients with advanced HCC with preserved liver function. Those involved in the care for patients with HCC should be encouraged to participate in well-designed clinical trials, to increase evidence-based knowledge and to make further progress.

KW - Chemoembolisation

KW - Hepatocellular carcinoma

KW - Liver transplantation

KW - Sorafenib

UR - http://www.scopus.com/inward/record.url?scp=67449135811&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdp281

DO - 10.1093/annonc/mdp281

M3 - Article

C2 - 19497945

AN - SCOPUS:67449135811

SN - 0923-7534

VL - 20

SP - 1

EP - 6

JO - Annals of Oncology

JF - Annals of Oncology

IS - SUPPL.7

ER -